API Pharma SRL
The score of API Pharma shows with a free account.
See the score- Summary? / 5
- Solvency
- Liquidity
- Interest coverage
- Profitability
- Leverage
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +2128 % Total assets +399 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →API Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 06 Jul 2026
- Year ended 31 Dec 2024filed on 08 Jul 2025
- Year ended 31 Dec 2023filed on 09 Jul 2024
API Pharma's financial analysis
- Solvency59.7%sector median: 41.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of API Pharma
API Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0805.949.739
- VAT number
- BE0805949739
- Peppol
- Registered · 0208:0805949739 · as of 21 Oct 2026
- Legal form
- SRL
- Incorporated
- 18 Sep 2023
- Registered office
- 4000 Liège
- Latest accounts
- 2025 · filed on 06 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
API Pharma (SRL) has been based in Liège since 2023, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 33,164 € and equity of 69,569 €; its revenue is not published. Its solvency stands at 59.7%, above the median of its sector (41.6%).
Companies similar to API Pharma
Companies in the same business, of comparable size and area, outside its group.
- Antha Consult Retail sale of pharmaceutical products Liège · balance sheet 272,102 €
- Belem Consulting Business and other management consultancy activities Liège · balance sheet 45,666 €
- Abocor Retail sale of pharmaceutical products Liège · balance sheet 10,389 €
- OVUM Bxl Public relations and communication activities Uccle · balance sheet 776,837 €
- Pharm'Training Lab Retail sale of pharmaceutical products Leuze-en-Hainaut · balance sheet 87,540 €
- Temapharm Retail sale of pharmaceutical products Neupré · balance sheet 191,548 €
- Farmacyze Retail sale of pharmaceutical products Ostend · balance sheet 73,863 €
- Tupharma Connect AND Trade Retail sale of pharmaceutical products Ghent · balance sheet 95,322 €
Frequently asked questions about API Pharma
What is the revenue of API Pharma?
API Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of API Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0805949739 for API Pharma, if the company is VAT-registered. Its company number (CBE) is 0805.949.739.
Where is the registered office of API Pharma?
According to the CBE register, the registered office of API Pharma is in 4000 Liège.
What is the equity of API Pharma?
At the close of the 2025 financial year, the equity of API Pharma amounts to 69,569 €, a solvency of 59.7% of total assets.
Who manages API Pharma?
The register lists 1 active mandates at API Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of API Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →